Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
03/24/2005 | WO2005026171A1 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d¸6,5-d']dipyrimidyne and 10-aza-analogue thereof |
03/24/2005 | WO2005026158A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
03/24/2005 | WO2005026130A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
03/24/2005 | WO2005026129A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
03/24/2005 | WO2005026126A1 Crf antagonists and heterobicyclic compounds |
03/24/2005 | WO2005026120A1 Matrix metalloproteinase inhibitors |
03/24/2005 | WO2005025681A2 A system for and a method of manufacturing personal golf putters |
03/24/2005 | WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
03/24/2005 | WO2005025293A2 Fused ring heterocycles as potassium channel modulators |
03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |
03/24/2005 | WO2005011657A3 Piperazine derivatives and their use as therapeutic agents |
03/24/2005 | WO2005005456A3 Peptide deformylase inhibitors |
03/24/2005 | WO2004111011A3 Synthesis of 2-aryl pyrimidine 4-carboxylic acid amides |
03/24/2005 | WO2004092144A3 Quinazoline compounds useful as p38 kinase inhibitors |
03/24/2005 | WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors |
03/24/2005 | US20050065211 Ester derivatives |
03/24/2005 | US20050065210 Anticholesterol agents; antilipemic agents; arteriosclerosis; cardiovascular disorders; parasiticides; antitumor agents; antiproliferative agents; antidiabetic agents |
03/24/2005 | US20050065174 Novel chain-breaking antioxidants |
03/24/2005 | US20050065173 Gene for spinal muscular atrophy |
03/24/2005 | US20050065166 Herbicides; plant safening agents |
03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
03/24/2005 | US20050065161 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
03/24/2005 | US20050065160 for the treatment and/or prophylaxis of diseases, in particular for use as antiviral agents, in particular against cytomegalo viruses |
03/24/2005 | US20050065148 Dipeptidyl peptidase inhibitors |
03/24/2005 | US20050065147 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
03/24/2005 | US20050065116 Thiazolopyrimidines useful as TNFalpha inhibitors |
03/24/2005 | US20050065095 Antibacterial agents |
03/24/2005 | CA2539049A1 Quinazoline derivatives |
03/24/2005 | CA2538909A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
03/24/2005 | CA2538413A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
03/24/2005 | CA2538315A1 Matrix metalloproteinase inhibitors |
03/24/2005 | CA2538026A1 Crf antagonists and heterobicyclic compounds |
03/24/2005 | CA2536633A1 Fused ring heterocycles as potassium channel modulators |
03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
03/23/2005 | EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto |
03/23/2005 | EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
03/23/2005 | EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
03/23/2005 | EP1516021A1 Printing process using specified azo compounds |
03/23/2005 | EP1515954A1 Method for producing 4,6-dichloro-5-fluoropyrimidine |
03/23/2005 | EP1515931A1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media |
03/23/2005 | EP1515723A2 Substituted dihydropyrimidones and dihydropyrimidinethiones as calcium channel blockers |
03/23/2005 | EP1381392A4 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
03/23/2005 | EP1028949B1 Carbamoylphenylsulfonyl ureas, method for their production and their application as herbicides and plant growth regulators |
03/23/2005 | CN1599727A Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
03/23/2005 | CN1599726A Pyrimidine compounds |
03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
03/23/2005 | CN1597672A Substituierte benzoylcyclohexandione |
03/23/2005 | CN1597671A Quinazoline deriative and preparation method and bioactivity |
03/23/2005 | CN1597668A Biamido heterocyclic derivative with antitumour activity and its preparation method and use |
03/23/2005 | CN1597667A Quinazoline derivatives as angiogenesis inhibitors |
03/23/2005 | CN1193991C Method for preparing 2.5-diamino-4.6-dichloropyrimidine |
03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
03/22/2005 | US6870053 Useful in treatment or prophylaxis of viral infections, for example, human immunodeficiency virus and hepatitis B virus |
03/22/2005 | US6869959 Heterocyclic carboxylic acid derivatives |
03/22/2005 | US6869943 Sorbitol dehydrogenase inhibitors |
03/17/2005 | WO2005023783A1 Process for the manufacture of gefitinib |
03/17/2005 | WO2005023781A1 Guanidine derivatives |
03/17/2005 | WO2005023780A1 Selective synthesis of cf3-substituted pyrimidines |
03/17/2005 | WO2005023779A1 Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6 -enoicacid] calcium salt |
03/17/2005 | WO2005023778A2 Process for preparation of rosuvastatin calcium |
03/17/2005 | WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
03/17/2005 | WO2005023204A2 Aromatic prodrugs of propofol, compositions and uses thereof |
03/17/2005 | WO2004113305A3 Diamino substituted quinazoline derivatives as promoters of smn2 |
03/17/2005 | WO2004092196A3 Tie-2 modulators and methods of use |
03/17/2005 | WO2004073642A3 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands |
03/17/2005 | WO2003053959A8 Heterocyclylamino carbonyluracils |
03/17/2005 | US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain |
03/17/2005 | US20050059810 Dibenzylamine compound and medicinal use thereof |
03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
03/17/2005 | US20050059687 Modulators of ATP-Binding Cassette transporters |
03/17/2005 | US20050059669 M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity |
03/17/2005 | US20050059668 Substituted acylpiperazine derivatives |
03/17/2005 | US20050059662 Substituted quinazolinone compounds |
03/17/2005 | US20050059651 Lactam derivatives as antagonists for human 11cby receptors |
03/17/2005 | CA2657076A1 Process for the preparation of rosuvastatin calcium |
03/17/2005 | CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
03/17/2005 | CA2536927A1 Guanidine derivatives |
03/16/2005 | EP1513820A2 Compounds, compositions, and methods |
03/16/2005 | EP1513819A1 Process for preparing (s)-tetrahydro-a-(1-methylethyl)-2-oxo-1(2h)- pyrimidineacetic acid |
03/16/2005 | EP1513802A1 Alpha-sulfonylamino-acetonitriles |
03/16/2005 | EP1513795A2 Propionic acid derivatives and their use as hppars activators |
03/16/2005 | EP1215200B1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same |
03/16/2005 | EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
03/16/2005 | CN1596247A Lactam derivatives as antagonists for human 11CBY receptors |
03/16/2005 | CN1596246A Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
03/16/2005 | CN1193019C Method and reagents for N-alkylating ureides |
03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
03/15/2005 | US6867214 Quinazoline derivatives and pharmaceutical applications thereof |
03/15/2005 | US6867213 Vitronectin receptor inhibitors; bone diseases, osteoporosis; esterification of acid form with isopropanol |
03/15/2005 | US6867212 6-(1-fluoroethyl)-5-iodo-4-aminopyrimidine compounds process for preparation of the same and pest controllers for agricultural and horticultural use |
03/15/2005 | US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics |
03/15/2005 | US6867208 Vitronectin receptor antagonists, their preparation and their use |
03/15/2005 | US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance |
03/15/2005 | US6867201 For therapy of abnormal cell growth, such as cancer, in mammals |
03/10/2005 | WO2005021553A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
03/10/2005 | WO2005021511A1 A novel process for amorphous rosuvastatin calcium |
03/10/2005 | WO2005021499A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
03/10/2005 | WO2005021498A1 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |